Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 8Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 18Prostatic Neoplasms, Castration-Resistant 3Neoplasm Metastasis 3Non-metastatic Castration-resistant Prostate Cancer 2Metastatic Castration Resistant Prostate Cancer 2Sleep Initiation and Maintenance Disorders 1Non-metastatic Prostate Cancer 1Metastatic Hormone-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Fatigue 1Epilepsy 1Depression 1Castration-resistant Prostate Cancer 1Brain Diseases 1Advanced Prostate Carcinoma 1

Interventions

enzalutamide 2Docetaxel 1Blood Specimen Collection 1Biopsy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Metastatic Castration Resistant Prostate Cancer × enzalutamide × Clear all
NCT03328364 2024-11-21

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Astellas Pharma Inc

Completed
211 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT02471469 2020-10-19

ILUMINATE

Radboud University Medical Center

Completed
40 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡